Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Telaprevir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00528528
What this trial is testing

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Who this might be right for
Chronic Hepatitis C
Tibotec BVBA 166
Not applicableEnded earlyNCT01716403
What this trial is testing

Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy

Who this might be right for
C Hepatitis, Tri Therapy
University Hospital, Grenoble 8
Early research (Phase 1)Study completedNCT01597895
What this trial is testing

Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

Who this might be right for
Healthy
ViiV Healthcare 14
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Not applicableUnknownNCT02057003
What this trial is testing

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Who this might be right for
Hepatitis C, ChronicHuman Immunodeficiency Virus
Valme University Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT00561015
What this trial is testing

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 52
Testing effectiveness (Phase 2)Study completedNCT00580801
What this trial is testing

An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Tibotec BVBA 24
Large-scale testing (Phase 3)Study completedNCT01513941
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Chronic Hepatitis C
Janssen-Cilag International NV 163
Early research (Phase 1)Study completedNCT01253551
What this trial is testing

VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir

Who this might be right for
Hepatitis C
Tibotec BVBA 21
Not applicableStudy completedNCT01577069
What this trial is testing

Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir

Who this might be right for
Chronic Hepatitis C
Association HGE CHU Bordeaux Sud 73
Testing effectiveness (Phase 2)Study completedNCT01581138
What this trial is testing

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 64
Early research (Phase 1)Study completedNCT01635829
What this trial is testing

Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir

Who this might be right for
Healthy Participants
Janssen Infectious Diseases BVBA 24
Not applicableStudy completedNCT02881034
What this trial is testing

Ribavirin Bioavailability After Telaprevir Exposure

Who this might be right for
Hepatitis C
Hospices Civils de Lyon 37
Early research (Phase 1)Study completedNCT00828789
What this trial is testing

VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer

Who this might be right for
Hepatitis CHCVHIV+1 more
Tibotec BVBA 20
Large-scale testing (Phase 3)Study completedNCT00780416
What this trial is testing

Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 189
Large-scale testing (Phase 3)WithdrawnNCT01858961
What this trial is testing

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT01332955
What this trial is testing

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Who this might be right for
Hepatitis C, ChronicHIV Infection
ANRS, Emerging Infectious Diseases 70
Testing effectiveness (Phase 2)Study completedNCT00372385
What this trial is testing

Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 334
Early research (Phase 1)Study completedNCT00933894
What this trial is testing

VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram

Who this might be right for
Hepatitis C
Tibotec BVBA 16
Large-scale testing (Phase 3)WithdrawnNCT01890772
What this trial is testing

Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1

Who this might be right for
Hepatitis C
Timothy Morgan, MD
Next Page